Translational Development Acquisition Income Statement (2023-2026) | TDAC

Income Statement Dec2023 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Selling, General & Administrative (Quarter) 0.13M0.35M0.22M0.21M0.16M0.28M
Other Operating Expenses (Quarter) 0.49M
Operating Expenses (Quarter) 0.49M0.13M0.35M0.22M0.21M0.16M0.28M
Operating Income (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
EBIT (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
Non-operating items
Non Operating Investment Income (Quarter) 0.13M
Other Non Operating Income (Quarter) 0.13M1.83M1.84M1.87M1.63M1.61M
Non Operating Income (Quarter) 0.13M1.83M1.84M1.87M1.76M1.61M
Net income details
EBT (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
Profit After Tax (Quarter) -0.01M1.48M1.62M1.66M1.60M1.33M
Income from Continuing Operations (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
Consolidated Net Income (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
Income towards Parent Company (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M
Net Income towards Common Stockholders (Quarter) 0.06M1.17M1.28M1.31M-2.40M0.28M
Additional items
EBITDA (Quarter) -0.13M-0.35M-0.22M-0.21M-0.16M-0.28M